XCRT Financials: Xcelerate Inc AI Analysis

Home

Stock

XCRT

Financials

XCRT Financial

Xcelerate Inc

0.25%

$0

At close: Apr 02, 16:00:00 GMT-4

Post-market: Apr 02, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0098

Open

$0.0099

Day's Range

$0.0098 - $0.0099

52 week range

$0.0061 - $0.0211

Volume

27.5K

Avg.Volume

95.6K

Dividend yield

EPS (TTM)

Market Cap

$4.3M

What is XCRT?

Xcelerate, Inc. is a medical company, which engages in the provision of acquiring intellectual property technology for medical applications. The company is headquartered in Mauldin, South Carolina. The company went IPO on 2004-10-06. The firm is engaged in three separate but related businesses within the medical, health and wellness sectors. The firm is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

XCRT Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	17,860	17,132	16,896	17,370	14,498	12,190
Revenue Growth (YoY)	6%	1%	-3%	20%	19%	14%
Cost of Revenue	13,789	13,242	13,170	13,586	11,255	9,526
Gross Profit	4,070	3,889	3,725	3,783	3,242	2,664
Selling, General & Admin	2,187	1,902	1,886	1,949	1,565	1,434
Research & Development	--	--	--	--	--	--
Operating Expenses	2,201	2,098	2,107	2,203	1,788	1,452
Other Non Operating Income (Expenses)	-41	-38	-22	-19	-40	-15
Pretax Income	1,684	1,658	1,525	1,742	1,345	1,079
Income Tax Expense	353	353	317	384	292	215
Net Income	603	519	482	502	467	401
Net Income Growth	19%	8%	-4%	7%	16%	25%
Shares Outstanding (Diluted)	68.19	68.19	78.86	83	83	83
Shares Change (YoY)	0%	-14%	-5%	0%	0%	0%
EPS (Diluted)	8.85	7.62	6.12	6.05	5.63	4.84
EPS Growth	19%	25%	1%	7%	16%	25%
Free Cash Flow	2,263	1,993	2,146	1,425	1,294	1,646
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	22.78%	22.7%	22.04%	21.77%	22.36%	21.85%
Operating Margin	10.46%	10.44%	9.57%	9.09%	10.02%	9.94%
Profit Margin	3.37%	3.02%	2.85%	2.89%	3.22%	3.28%
Free Cash Flow Margin	12.67%	11.63%	12.7%	8.2%	8.92%	13.5%
EBITDA	2,647	2,619	2,492	2,472	2,243	1,918
EBITDA Margin	14.82%	15.28%	14.74%	14.23%	15.47%	15.73%
D&A For EBITDA	778	829	874	892	790	706
EBIT	1,869	1,790	1,618	1,580	1,453	1,212
EBIT Margin	10.46%	10.44%	9.57%	9.09%	10.02%	9.94%
Effective Tax Rate	20.96%	21.29%	20.78%	22.04%	21.71%	19.92%

Follow-Up Questions

What are Xcelerate Inc's key financial statements?



According to the latest financial statement (Form-10K), Asseco Poland S.A. has a total asset of $20,328, Net profit of $519

What are the key financial ratios for XCRT?



Asseco Poland S.A.'s Current ratio is 1.37, has a Net margin is 3.02, sales per share of $251.23.

How is Xcelerate Inc's revenue broken down by segment or geography?



Asseco Poland S.A. largest revenue segment is Formula Systems, at a revenue of 10,907,100,000 in the most earnings release.For geography, Israel is the primary market for Asseco Poland S.A., at a revenue of 6,622,600,000.

Is Xcelerate Inc profitable?



yes, according to the latest financial statements, Asseco Poland S.A. has a net profit of $519

Does Xcelerate Inc have any liabilities?



yes, Asseco Poland S.A. has liability of 14,833

How many outstanding shares for Xcelerate Inc?



Asseco Poland S.A. has a total outstanding shares of 68.19

Xcelerate Inc (XCRT) Financial

XCRT Stock Price Chart